Patent · US Active

Spiroindolinone derivatives

US7776875B2 · kind B2 · utility

17Cited by

1References

12Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Li Chen · Shanghai, CN
Xingchun Han · Shanghai, CN
Yun He · San Diego, US
Song Yang · Shanghai, CN
Zhuming Zhang · Fryeburg, US

Key dates

Filing date	Nov 18, 2008
Grant date	Aug 17, 2010
Priority date	—
Expiry date	Nov 18, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are provided compounds of the formulaand pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.